Ricciuti, B.; Recondo, G.; Spurr, L. F.; Li, Y. Y.; Lamberti, G.; Venkatraman, D.; Umeton, R.; Cherniack, A. D.; Nishino, M.; Sholl, L. M.; Shapiro, G. I.; Awad, M. M.; Cheng, M. L., Impact of DNA Damage Response and Repair (DDR) Gene Mutations on Efficacy of PD-(L)1 Immune Checkpoint Inhibition in Non–Small Cell Lung Cancer, «CLINICAL CANCER RESEARCH», 2020, 26, pp. 4135 - 4142 [articolo]
Maggio I.; Manuzzi L.; Lamberti G.; Ricci A.D.; Tober N.; Campana D., Landscape and future perspectives of immunotherapy in neuroendocrine neoplasia, «CANCERS», 2020, 12, pp. 832 - 856 [articolo]Open Access
Recondo G.; Bahcall M.; Spurr L.F.; Che J.; Ricciuti B.; Leonardi G.C.; Lo Y.-C.; Li Y.Y.; Lamberti G.; Nguyen T.; Milan M.S.D.; Venkatraman D.; Umeton R.; Paweletz C.P.; Albayrak A.; Cherniack A.D.; Price K.S.; Fairclough S.R.; Nishino M.; Sholl L.M.; Oxnard G.R.; Janne P.A.; Awad M.M., Molecular Mechanisms of Acquired Resistance to MET Tyrosine Kinase Inhibitors in Patients with MET Exon 14–Mutant NSCLC, «CLINICAL CANCER RESEARCH», 2020, 26, pp. 2615 - 2625 [articolo]
Brighi, Nicole; La Rosa, Stefano; Rossi, Giulio; Grillo, Federica; Pusceddu, Sara; Rinzivillo, Maria; Spada, Francesca; Tafuto, Salvatore; Massironi, Sara; Faggiano, Antongiulio; Antonuzzo, Lorenzo; Santini, Donatella; Sessa, Fausto; Maragliano, Roberta; Gelsomino, Fabio; Albertelli, Manuela; Vernieri, Claudio; Panzuto, Francesco; Fazio, Nicola; De Divitiis, Chiara; Lamberti, Giuseppe; Colao, Annamaria; Fave, Gianfranco Delle; Campana, Davide, Morphological Factors Related to Nodal Metastases in Neuroendocrine Tumors of the Appendix: A Multicentric Retrospective Study, «ANNALS OF SURGERY», 2020, 271, pp. 527 - 533 [articolo]
Lamberti G.; Gelsomino F.; Brocchi S.; Poerio A.; Melotti B.; Sperandi F.; Gargiulo M.; Borghi C.; Fiorentino M.; Ardizzoni A., New disappearance of complicated atheromatous plaques on rechallenge with PD-1/PD-L1 axis blockade in non-small cell lung cancer patient: follow up of an unexpected event, «THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY», 2020, 12, pp. 1 - 6 [articolo]Open Access
Lamberti, G.; Faggiano, A.; Brighi, N.; Tafuto, S.; Ibrahim, T.; Brizzi, M. P.; Pusceddu, S.; Albertelli, M.; Massironi, S.; Panzuto, F.; Badalamenti, G.; Riccardi, F.; Butturini, G.; Gelsomino, F.; De Divitiis, C.; Modica, R.; Bongiovanni, A.; La Salvia, A.; Torchio, M.; Colao, A.; Ferone, D.; Campana, D., Nonconventional Doses of Somatostatin Analogs in Patients With Progressing Well-Differentiated Neuroendocrine Tumor, «THE JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM», 2020, 105, pp. 194 - 200 [articolo]
Gelsomino, F.; Di Federico, A.; Filippini, D. M.; Dall'Olio, F. G.; Lamberti, G.; Sperandi, F.; Balacchi, C.; Brocchi, S.; Ardizzoni, A., Overcoming Primary Resistance to PD-1 Inhibitor With Anti–PD-L1 Agent in Squamous-Cell NSCLC: Case Report, «CLINICAL LUNG CANCER», 2020, 21, pp. E45 - E48 [articolo]
Lamberti, Giuseppe; Brizzi, Maria Pia; Pusceddu, Sara; Gelsomino, Fabio; Di Meglio, Giovanni; Massari, Francesco; Badalamenti, Giuseppe; Riccardi, Ferdinando; Ibrahim, Toni; Ciccarese, Chiara; Buti, Sebastiano; Carnaghi, Carlo; Prinzi, Natalie; Panzuto, Francesco; Campana, Davide, Perioperative Chemotherapy in Poorly Differentiated Neuroendocrine Neoplasia of the Bladder: A Multicenter Analysis, «JOURNAL OF CLINICAL MEDICINE», 2020, 9, Article number: 1351, pp. 1 - 12 [articolo]Open Access
Gelsomino F.; Tiseo M.; Barbieri F.; Riccardi F.; Cavanna L.; Frassoldati A.; Delmonte A.; Longo L.; Dazzi C.; Cinieri S.; Colantonio I.; Sperandi F.; Lamberti G.; Brocchi S.; Tofani L.; Boni L.; Ardizzoni A., Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL), «BRITISH JOURNAL OF CANCER», 2020, 123, pp. 26 - 32 [articolo]Open Access
Chiari R.; Ricciuti B.; Landi L.; Morelli A.M.; Delmonte A.; Spitaleri G.; Cortinovis D.L.; Lamberti G.; Facchinetti F.; Pilotto S.; Verusio C.; Chella A.; Bonanno L.; Galetta D.; Cappuzzo F., ROS1-rearranged Non–small-cell Lung Cancer is Associated With a High Rate of Venous Thromboembolism: Analysis From a Phase II, Prospective, Multicenter, Two-arms Trial (METROS), «CLINICAL LUNG CANCER», 2020, 21, pp. 15 - 20 [articolo]
Lamberti G.; Manuzzi L.; Maggio I.; Campana D., Should we lose hope in adjuvant therapy for neuroendocrine tumors?—In response to: Adjuvant therapy following resection of gastroenteropancreatic neuroendocrine tumors provides no recurrence or survival benefit, «JOURNAL OF SURGICAL ONCOLOGY», 2020, 122, pp. 570 - 571 [replica/breve intervento]
Lamberti G.; Andrini E.; Sisi M.; Di Federico A.; Ricciuti B., Targeting DNA damage response and repair genes to enhance anticancer immunotherapy: Rationale and clinical implication, «FUTURE ONCOLOGY», 2020, 16, pp. 1751 - 1766 [articolo]
Maggio I.; Mollica V.; Brighi N.; Lamberti G.; Manuzzi L.; Ricci A.D.; Campana D., The functioning side of the pancreas: a review on insulinomas, «JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION», 2020, 43, pp. 139 - 148 [articolo]
Lamberti G.; Sisi M.; Andrini E.; Palladini A.; Giunchi F.; Lollini P.-L.; Ardizzoni A.; Gelsomino F., The mechanisms of PD-L1 regulation in non-small-cell lung cancer (NSCLC): Which are the involved players?, «CANCERS», 2020, 12, Article number: 3129, pp. 1 - 21 [articolo]Open Access
De Giglio, A.; Lamberti, G.; Facchinetti, F.; Genova, C.; Andrini, E.; Dal Bello, M. G.; Tiseo, M.; Metro, G.; Chiari, R.; Ricciuti, B., Treatment Patterns and Clinical Outcomes Among Patients With ROS1-rearranged Non–small-cell Lung Cancer Progressing on Crizotinib, «CLINICAL LUNG CANCER», 2020, 21, pp. 478 - 487 [articolo]
